fam-trastuzumab deruxtecan-nxki (Enhertu) Report issue

Biologics mAb ADC Approved FDA Fast Track FDA Accelerated Approval FDA
AACT ChEMBL
Back

Drug Pricing Summary

VA Big4

$1734.3400

VA FSS

$2261.3600

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
trastuzumab deruxtecan 100 mg / 5 mL (5 mL INJECTION) $1734.3400 VA Big4
  • Enhertu (1)
    		•  Daiichi Sankyo, Inc.
    trastuzumab deruxtecan 100 mg / 5 mL (5 mL INJECTION) $2261.3600 VA FSS
  • Enhertu (1)
    		•  Daiichi Sankyo, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue